Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ADHERIUM LIMITED Director's Dealing 2021

May 18, 2021

64305_rns_2021-05-18_84b2e291-9f5d-4901-8c2b-70c28f7f0649.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Adherium Limited
ACN 605 352 510

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director George Baran
Date of appointment 13 May 2021

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of Securities Note: Provide details of the circumstances giving rise to the relevant interest. Trudell Medical Limited, in (a) 422,697,512 fully paid ordinary shares which the director has a 33.33% (b) 10,485,950 options over fully paid beneficial interest. ordinary shares, each with a $0.0219 exercise price and 29 January 2027 expiry Trudell Medical Limited is a date significant shareholder of Adherium.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Not applicable
Nature of interest Not applicable
Name of registered holder(if issued securities) Not applicable
No. and class of securities to whichinterest relates Not applicable
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002